Marker Therapeutics Inc (MRKR)

[GoIrish1776]

If I understand MD, saying AML data can’t compete. No comment on PC data.

I believe PC data posted at ASCO site is a high level overview of current data or at least data at submission. Could there be more or updated data in late May, maybe. More likely is we’ll just get more detail, eg, 8 or 13 went longer wo disease progression than expected, 2 of the 5 had first injection such that still not reached the mean expected progression date (if that makes sense) so effectively 8 of 11 lasted longer wo disease progression (2 still unsure). Just an example of the type of detail we might get. Not actual data! We could also see some tend data which could be interesting. But I don’t expect to see, for instance, new data like 20 dosed, 2 CRs, etc. Could be wrong obviously.